Bausch & Lomb Incorporated

Bausch & Lomb Incorporated, operating through its Surgical Division as a for-profit manufacturer of ophthalmic and surgical medical devices, supplies intraocular lenses, surgical instruments, eye shields, and pharmaceutical ophthalmic products to the Defense Logistics Agency and the Department of Veterans Affairs as a prime contractor, with no set-aside designations across a competitive full-and-open posture.

Bausch & Lomb is headquartered in Rochester, New York, and is a subsidiary of parent company Bausch Health US LLC (based in Bridgewater, New Jersey). The vendor manufactures surgical appliances, medicinal and botanical products, and medical instruments under primary NAICS categories 325411 (Medicinal and Botanical Manufacturing), 339113 (Surgical Appliance and Supplies Manufacturing), and 339112 (Surgical and Medical Instrument Manufacturing). Recent award activity shows 1,526 prime contracts and task orders totaling $48.4 million in combined potential value across 29 distinct customer agencies since 2001, with $6.4 million obligated (13% of total potential value).

Customer concentration is heavily skewed toward defense and veterans' healthcare. The Defense Logistics Agency Troop Support Medical commands 838 awards ($20.7 million combined potential value), representing 55% of all awards in the source data. The Department of Veterans Affairs Headquarters accounts for $10.5 million across five awards (primarily a single $1.43 million indefinite delivery contract for intraocular lens implants running through December 2026), while the Department of the Army Medical Command holds 14 awards worth $6.9 million. The top five customers account for 65% of award count and 90% of combined potential value. The two rankings reveal a pronounced divergence: while DLA Troop Support Medical dominates both volume and dollars, the VA Headquarters' five awards anchor most of the dollar exposure through a small number of large indefinite delivery vehicles.

Bausch & Lomb places the vast majority of work against two agency-specific indefinite delivery contracts: Indefinite Delivery Contract SPM2D012D0011 (384 task orders, $489 thousand combined potential value) and Indefinite Delivery Contract SPE2D020D0012 (363 task orders, $282 thousand combined potential value), both under DLA Troop Support Medical. A Navy contract vehicle (N0018302A0001) carries 73 task orders. Bausch & Lomb also holds a $1.43 million single-award IDC with VA Headquarters for intraocular lens implants awarded December 21, 2023, through December 20, 2026, structured as firm fixed price with no set-aside.

Activity has grown year over year — 47 awards in 2022 to 127 in 2024 — before moderating to 112 in 2025 and 14 in the first quarter of 2026. Only three awards ($219 thousand combined potential value) reach completion in the next twenty-four months, leaving minimal recompete exposure in that window. The award portfolio is granular: the majority of DLA orders are small delivery orders and purchase orders (typically $65–$940 per order) for individual surgical instruments, eye shields, holder suture needles, surgical forceps, blades, and hydroxypropyl methylcellulose, interspersed with occasional larger orders such as a $38.6 thousand other-medical delivery order (July 2025) and a $129 thousand Stellaris Elite Phaco machine and handpiece order from VA VISN 15 (August 2024). Representative work includes a $1.43 million VA Headquarters IDC for intraocular lens implants (December 2023), a $96.75 thousand Stellaris Service Agreement with VA VISN 10 (May 2025), and a $36.5 thousand DLA other-medical delivery order (August 2024). The PSC breakdown reflects this product mix: 690 awards in Drugs and Biologicals (PSC 6505), 654 in Medical and Surgical Instruments, Equipment, and Supplies (PSC 6515), and 72 in Ophthalmic Instruments, Equipment, and Supplies (PSC 6530).

Bausch & Lomb competes full-and-open across all work; no awards carry set-aside designations. The company operates as a pure-play supplier to federal medical and surgical procurement without set-aside positioning or teaming relationships visible in the source data. Performance is centered at Rochester, New York, with occasional site-specific delivery (Cleveland, Columbia, Fredericksburg VA Medical Centers). The vendor has maintained federal contractor status since at least 2001 and demonstrates consistent, high-volume transactional engagement with DLA medical supply chains rather than complex systems integration or large prime contracts.